- Investing Ideas
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
6
Companies with a Value score of at least 3, ordered by Value score
6 companies
Gilead Sciences
Market Cap: CL$184.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDCL
CL$134,210.00
7D
5.7%
1Y
69.9%
Gilead Sciences
Market Cap: US$184.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$146.74
7D
5.6%
1Y
32.9%
Amgen
Market Cap: CL$239.1b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGNCL
CL$405,950.00
7D
5.9%
1Y
38.3%
Biogen
Market Cap: CL$32.6b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBCL
CL$199,500.00
7D
4.3%
1Y
41.6%
Amgen
Market Cap: US$239.1b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$443.84
7D
5.8%
1Y
73.9%
Biogen
Market Cap: US$32.6b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$218.12
7D
4.3%
1Y
67.5%